STAT3 and familial dilated cardiomyopathy: Alogliptin and evogliptin enhance cardiac mitogenesis via PGC-1α/NRF1/TFAM signaling in DCM, while sitagliptin restores renal mitochondrial dynamics through SDF-1α/CXCR4/STAT3.